JPWO2021133167A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021133167A5 JPWO2021133167A5 JP2022539245A JP2022539245A JPWO2021133167A5 JP WO2021133167 A5 JPWO2021133167 A5 JP WO2021133167A5 JP 2022539245 A JP2022539245 A JP 2022539245A JP 2022539245 A JP2022539245 A JP 2022539245A JP WO2021133167 A5 JPWO2021133167 A5 JP WO2021133167A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- amino acid
- seq
- acid sequence
- βrii
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023060823A JP2023076596A (ja) | 2019-12-24 | 2023-04-04 | ＴＧＦ－βＲＩＩ結合タンパク質 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL2024576 | 2019-12-24 | ||
| NL2024576 | 2019-12-24 | ||
| PCT/NL2020/050813 WO2021133167A1 (fr) | 2019-12-24 | 2020-12-22 | Protéines de liaison tgf-bêta-rii |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023060823A Division JP2023076596A (ja) | 2019-12-24 | 2023-04-04 | ＴＧＦ－βＲＩＩ結合タンパク質 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023508202A JP2023508202A (ja) | 2023-03-01 |
| JPWO2021133167A5 true JPWO2021133167A5 (fr) | 2023-04-25 |
Family
ID=69700252
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022539245A Pending JP2023508202A (ja) | 2019-12-24 | 2020-12-22 | ＴＧＦ－βＲＩＩ結合タンパク質 |
| JP2023060823A Pending JP2023076596A (ja) | 2019-12-24 | 2023-04-04 | ＴＧＦ－βＲＩＩ結合タンパク質 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023060823A Pending JP2023076596A (ja) | 2019-12-24 | 2023-04-04 | ＴＧＦ－βＲＩＩ結合タンパク質 |
Country Status (12)
| Country | Link |
|---|---|
| EP (2) | EP4269433A3 (fr) |
| JP (2) | JP2023508202A (fr) |
| KR (2) | KR20220117267A (fr) |
| CN (3) | CN116375869A (fr) |
| AR (1) | AR120914A1 (fr) |
| AU (2) | AU2020412201A1 (fr) |
| BR (1) | BR112022012522A2 (fr) |
| CA (1) | CA3165605A1 (fr) |
| IL (2) | IL294181A (fr) |
| MX (2) | MX2022007919A (fr) |
| TW (2) | TW202128747A (fr) |
| WO (1) | WO2021133167A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CR20240201A (es) * | 2021-11-19 | 2024-07-15 | Merus Nv | Unidades de unión multiespecíficas que comprenden los dominios de unión a pd-1 y tgf-brii |
| US20240218070A1 (en) | 2022-12-20 | 2024-07-04 | Merus N.V. | FAP BINDING DOMAINS AND BISPECIFIC BINDING MOIETIES THAT BIND FAP AND TGF-ßRII |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001206899A (ja) * | 1999-11-18 | 2001-07-31 | Japan Tobacco Inc | ＴＧＦ−βＩＩ型受容体に対するヒトモノクローナル抗体及びその医薬用途 |
| SI1523496T1 (sl) | 2002-07-18 | 2011-11-30 | Merus B V | Rekombinantno proizvajanje zmesi protiteles |
| PT2147594E (pt) | 2008-06-27 | 2014-02-17 | Merus B V | Mamíferos não humanos que produzem anticorpos |
| JO3096B1 (ar) | 2008-11-07 | 2017-03-15 | Imclone Llc | الأجسام المضادة لمستقبل ii مضاد tgfb |
| MA34820B1 (fr) * | 2011-01-06 | 2014-01-02 | Glaxo Group Ltd | Ligandise se liant au récepteur ii du tgf-bêta |
| BR112015006824A2 (pt) | 2012-09-27 | 2017-07-04 | Merus B V | anticorpo igg biespecífico, método para produzir um anticorpo igg biespecífico, anticorpo, composição farmacêutica e uso de um anticorpo igg biespecífico |
| AR109770A1 (es) * | 2016-10-18 | 2019-01-23 | Lilly Co Eli | ANTICUERPOS DEL RECEPTOR II DE TGF-b |
| JP2021519610A (ja) | 2018-03-30 | 2021-08-12 | メルス ナムローゼ フェンノートシャップ | 多価抗体 |
-
2020
- 2020-12-22 CA CA3165605A patent/CA3165605A1/fr active Pending
- 2020-12-22 BR BR112022012522A patent/BR112022012522A2/pt unknown
- 2020-12-22 CN CN202211726434.0A patent/CN116375869A/zh active Pending
- 2020-12-22 IL IL294181A patent/IL294181A/en unknown
- 2020-12-22 CN CN202080094188.4A patent/CN115038497A/zh active Pending
- 2020-12-22 AU AU2020412201A patent/AU2020412201A1/en active Pending
- 2020-12-22 MX MX2022007919A patent/MX2022007919A/es unknown
- 2020-12-22 JP JP2022539245A patent/JP2023508202A/ja active Pending
- 2020-12-22 KR KR1020227023748A patent/KR20220117267A/ko unknown
- 2020-12-22 EP EP23189839.6A patent/EP4269433A3/fr active Pending
- 2020-12-22 WO PCT/NL2020/050813 patent/WO2021133167A1/fr unknown
- 2020-12-22 CN CN202211726462.2A patent/CN116199780A/zh active Pending
- 2020-12-22 EP EP20829233.4A patent/EP4081306A1/fr active Pending
- 2020-12-22 KR KR1020237034290A patent/KR20230145542A/ko active Application Filing
- 2020-12-23 AR ARP200103661A patent/AR120914A1/es unknown
- 2020-12-23 TW TW109145819A patent/TW202128747A/zh unknown
- 2020-12-23 TW TW112150430A patent/TW202417513A/zh unknown
-
2022
- 2022-06-23 MX MX2024002182A patent/MX2024002182A/es unknown
-
2023
- 2023-02-13 AU AU2023200779A patent/AU2023200779A1/en active Pending
- 2023-04-04 JP JP2023060823A patent/JP2023076596A/ja active Pending
- 2023-07-09 IL IL304317A patent/IL304317A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11578131B2 (en) | Polynucleotides encoding death domain-containing receptor-5 (DR5) binding molecules | |
| EP3889172B1 (fr) | Inhibition ciblee de facteur de croissance de transformation bêta (tgfbeta) | |
| JP7323513B2 (ja) | 抗４－１ｂｂ抗体とその作製及び使用方法 | |
| US11872271B2 (en) | High-affinity anti-VEGF antibody KLHa505 | |
| JP2024125370A (ja) | クローディン１８．２結合部分およびその利用 | |
| JP2020513809A5 (fr) | ||
| RU2013125459A (ru) | АНТИТЕЛА ПРОТИВ БЕЛКА РЕЦЕПТОРА c-Met | |
| KR102360967B1 (ko) | 신규 항-네트린-1 항체 | |
| JP6925981B2 (ja) | Ｖｅｇｆとｎｒｐ１との結合を阻害する抗体 | |
| JP2022507679A (ja) | Ｈｅｒ２／ｐｄ１二重特異性抗体 | |
| US20240117035A1 (en) | Cldn18.2/cd3 bispecific antibodies for the therapy of cldn18.2-expressing solid tumors | |
| WO2020200256A1 (fr) | Protéine de fusion et son utilisation | |
| JP2023076596A5 (fr) | ||
| JP2024530970A (ja) | 抗－ｂ７－ｈ４／抗－４－１ｂｂ二重特異的抗体およびこれの用途 | |
| CN117940453A (zh) | 特异性结合pd-1的蛋白及其医药用途 | |
| JP2022522815A (ja) | Ｔｓｇ－６抗体およびその用途 | |
| CA3148291A1 (fr) | Methodes de traitement du cancer par l'utilisation d'inhibiteurs de l'axe pd-1 et d'anticorps anti-periostine | |
| JPWO2021133167A5 (fr) | ||
| JP2023531042A (ja) | ４－１ｂｂ結合タンパク質及びその用途 | |
| CN115515980A (zh) | C19 c38双特异性抗体 | |
| US20220153869A1 (en) | Shielded and homing bispecific antibody that simultaneously inhibits angiogenic pathway targets and her2 family proteins and uses thereof |